pexelizumab

Known as: h5G1.1-SC, h5G1.1-scFv 
 

Topic mentions per year

Topic mentions per year

1999-2014
0246819992014

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
OBJECTIVE The previous Pexelizumab for Reduction of Infarction and Mortality in Coronary Artery Bypass Graft Surgery I (PRIMO… (More)
Is this relevant?
2008
2008
BACKGROUND Primary percutaneous coronary angioplasty is an effective and widely adopted treatment for acute myocardial infarction… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • table 4
Is this relevant?
Highly Cited
2007
Highly Cited
2007
CONTEXT Reperfusion with percutaneous transluminal coronary intervention (PCI) is effective at improving outcomes in patients… (More)
Is this relevant?
2006
2006
BACKGROUND Morbidity and mortality after coronary artery bypass graft surgery are directly related to specific preoperative risk… (More)
Is this relevant?
2005
2005
AIMS Pexelizumab, a monoclonal antibody inhibiting C5, reduced 90 day mortality and shock in the COMplement inhibition in… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
Is this relevant?
2004
2004
CONTEXT Inflammation and ischemia-reperfusion injury during coronary artery bypass graft (CABG) surgery requiring cardiopulmonary… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
2004
2004
BACKGROUND During cardiac surgery requiring cardiopulmonary bypass, pro-inflammatory complement pathways are activated by… (More)
Is this relevant?
2004
2004
BACKGROUND AND PURPOSE Pharmacological modulation of complement activation recently has been postulated as a therapeutic target… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
Highly Cited
2003
Highly Cited
2003
BACKGROUND Complement, activated during myocardial ischemia and reperfusion, causes myocardial damage through multiple processes… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
1999
1999
We have previously shown that reoxygenation of hypoxic human umbilical vein endothelial cells (HUVECs) leads to the activation… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?